GLP-1 agonists and lean body mass loss part 2 w/ Dr. Grant Tinsley

from Docs Who Lift · host Docs Who Lift

Drs. Karl and Spencer bring back Dr. Grant Tinsley, a body composition researcher, to go over the GLP-1 data (semaglutide and tirzepatide) in terms of lean body mass loss. Learn:- How much lean body mass is lost in these trials- How body composition is measured- How is muscle loss assessed- Should you be worried if you're taking a GLP-1 agonist Read Dr. Tinsley's blog Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Episode metadata supplied by the publisher feed · Published Apr 24, 2023

Embed this episode

Attribution link and audio player

What this episode covers

Drs. Karl and Spencer bring back Dr. Grant Tinsley, a body composition researcher, to go over the GLP-1 data (semaglutide and tirzepatide) in terms of lean body mass loss. Learn: - How much lean body mass is lost in these trials - How body composition is measured - How is muscle loss assessed - Should you be worried if you're taking a GLP-1 agonist Read Dr. Tinsley's blog Become a Sequence patient (evaluation for GLP-1 agonist)

Distinct summary based on available episode metadata or transcript content.

NOW PLAYING

GLP-1 agonists and lean body mass loss part 2 w/ Dr. Grant Tinsley

0:00 41:45

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Docs Who Lift?

This episode is 41 minutes long.

When was this Docs Who Lift episode published?

This episode was published on April 24, 2023.

Can I download this Docs Who Lift episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!